These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 36470502)

  • 1. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review.
    Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK
    Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of clinical evidence of antiviral therapy for human monkeypox: A scoping review.
    Kuroda N; Shimizu T; Hirano D; Ishikane M; Kataoka Y
    J Infect Chemother; 2023 Feb; 29(2):228-231. PubMed ID: 36283609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
    Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and Vaccination for Smallpox and Monkeypox.
    Saalbach KP
    Adv Exp Med Biol; 2024; 1451():301-316. PubMed ID: 38801586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus.
    DeLaurentis CE; Kiser J; Zucker J
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0122622. PubMed ID: 36374026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox.
    Hung YP; Lee CC; Lee JC; Chiu CW; Hsueh PR; Ko WC
    J Microbiol Immunol Infect; 2022 Oct; 55(5):795-802. PubMed ID: 36115792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical considerations on monkeypox antiviral medications: An overview.
    Pourkarim F; Entezari-Maleki T
    Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak.
    Almehmadi M; Allahyani M; Alsaiari AA; Alshammari MK; Alharbi AS; Hussain KH; Alsubaihi LI; Kamal M; Alotaibi SS; Alotaibi AN; Aldhafeeri AA; Imran M
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies.
    Rabaan AA; Abas AH; Tallei TE; Al-Zaher MA; Al-Sheef NM; Fatimawali ; Al-Nass EZ; Al-Ebrahim EA; Effendi Y; Idroes R; Alhabib MF; Al-Fheid HA; Adam AA; Bin Emran T
    J Med Virol; 2023 Jan; 95(1):e28306. PubMed ID: 36372558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis.
    Shamim MA; Satapathy P; Padhi BK; Veeramachaneni SD; Akhtar N; Pradhan A; Agrawal A; Dwivedi P; Mohanty A; Pradhan KB; Kabir R; Rabaan AA; Alotaibi J; Al Ismail ZA; Alsoliabi ZA; Al Fraij A; Sah R; Rodriguez-Morales AJ
    Front Pharmacol; 2023; 14():1149909. PubMed ID: 37214444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential therapeutic targets for Mpox: the evidence to date.
    Byrareddy SN; Sharma K; Sachdev S; Reddy AS; Acharya A; Klaustermeier KM; Lorson CL; Singh K
    Expert Opin Ther Targets; 2023; 27(6):419-431. PubMed ID: 37368464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations.
    Frenois-Veyrat G; Gallardo F; Gorgé O; Marcheteau E; Ferraris O; Baidaliuk A; Favier AL; Enfroy C; Holy X; Lourenco J; Khoury R; Nolent F; Grosenbach DW; Hruby DE; Ferrier A; Iseni F; Simon-Loriere E; Tournier JN
    Nat Microbiol; 2022 Dec; 7(12):1951-1955. PubMed ID: 36344621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models.
    Cinatl J; Bechtel M; Reus P; Ott M; Rothweiler F; Michaelis M; Ciesek S; Bojkova D
    J Med Virol; 2024 Jan; 96(1):e29354. PubMed ID: 38180134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques.
    Russo AT; Grosenbach DW; Brasel TL; Baker RO; Cawthon AG; Reynolds E; Bailey T; Kuehl PJ; Sugita V; Agans K; Hruby DE
    J Infect Dis; 2018 Sep; 218(9):1490-1499. PubMed ID: 29982575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2022 Monkeypox outbreak: How the medicinal chemistry could help us?
    Silva-Júnior EFD
    Bioorg Med Chem; 2022 Nov; 73():117036. PubMed ID: 36183614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.
    Berhanu A; Prigge JT; Silvera PM; Honeychurch KM; Hruby DE; Grosenbach DW
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4296-300. PubMed ID: 25896687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review to identify novel clinical characteristics of monkeypox virus infection and therapeutic and preventive strategies to combat the virus.
    Chenchula S; Ghanta MK; Amerneni KC; Rajakarunakaran P; Chandra MB; Chavan M; Gupta R
    Arch Virol; 2023 Jun; 168(7):195. PubMed ID: 37386209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monkeypox infection: The past, present, and future.
    Upadhayay S; Arthur R; Soni D; Yadav P; Navik U; Singh R; Gurjeet Singh T; Kumar P
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109382. PubMed ID: 36330915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tecovirimat Resistance in Mpox Patients, United States, 2022-2023.
    Smith TG; Gigante CM; Wynn NT; Matheny A; Davidson W; Yang Y; Condori RE; O'Connell K; Kovar L; Williams TL; Yu YC; Petersen BW; Baird N; Lowe D; Li Y; Satheshkumar PS; Hutson CL
    Emerg Infect Dis; 2023 Dec; 29(12):2426-2432. PubMed ID: 37856204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antivirals With Activity Against Mpox: A Clinically Oriented Review.
    Siegrist EA; Sassine J
    Clin Infect Dis; 2023 Jan; 76(1):155-164. PubMed ID: 35904001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.